CompletedNCT01605539
Cannabidiol and Opioid Cravings After Heroin Use
About this title
Read the official source —Medication studyAges 21–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMay 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Hurd,Yasmin, Ph.D.
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT01605539
- Official title
Show the full official title
Cannabidiol as Treatment Intervention for Opioid Relapse
Get this study by email
Recruitment & locations
CompletedNew York
Questions about this study
Who is behind this study?
The study sponsor is Hurd,Yasmin, Ph.D.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol 400, Cannabidiol 800 and Control.
Who was this study for?
Listed age limits: 21 years to 65 years.
